Skip to main content
. 2021 Aug 7;9(2):347–364. doi: 10.1007/s40487-021-00167-z

Fig. 4.

Fig. 4

QUADRA trial profile and overall response rates by HRD and platinum status. Platinum Res/Ref platinum chemotherapy-resistant or -refractory, PARPi PARP inhibitor